Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 3
2010 4
2011 4
2012 3
2013 4
2014 2
2015 1
2016 12
2017 10
2018 10
2019 7
2020 3
2021 6
2022 4
2023 5
2024 9
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Avapritinib versus Placebo in Indolent Systemic Mastocytosis.
Gotlib J, Castells M, Elberink HO, Siebenhaar F, Hartmann K, Broesby-Olsen S, George TI, Panse J, Alvarez-Twose I, Radia DH, Tashi T, Bulai Livideanu C, Sabato V, Heaney M, Van Daele P, Cerquozzi S, Dybedal I, Reiter A, Pongdee T, Barete S, Ustun C, Schwartz L, Ward BR, Schafhausen P, Vadas P, Bose P, DeAngelo DJ, Rein L, Vachhani P, Triggiani M, Bonadonna P, Rafferty M, Butt NM, Oh ST, Wortmann F, Ungerstedt J, Guilarte M, Taparia M, Kuykendall AT, Arana Yi C, Ogbogu P, Gaudy-Marqueste C, Mattsson M, Shomali W, Giannetti MP, Bidollari I, Lin HM, Sulllivan E, Mar B, Scherber R, Roche M, Akin C, Maurer M. Gotlib J, et al. Among authors: bulai livideanu c. NEJM Evid. 2023 Jun;2(6):EVIDoa2200339. doi: 10.1056/EVIDoa2200339. Epub 2023 May 23. NEJM Evid. 2023. PMID: 38320129 Clinical Trial.
Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes.
Polivka L, Madrange M, Bulai-Livideanu C, Barete S, Ballul T, Neuraz A, Greco C, Agopian J, Brenet F, Dubreuil P, Burdet C, Lemal R, Tournilhac O, Terriou L, Launay D, Bouillet L, Gourguechon C, Damaj G, Frenzel L, Meni C, Bouktit H, Collange AF, Gaudy-Marqueste C, Gousseff M, Le Mouel E, Hamidou M, Neel A, Ranta D, Jaussaud R, Guilpain P, Canioni D, Molina TJ, Bruneau J, Lhermitte L, Garcelon N, Javier RM, Pelletier F, Castelain F, Retornaz F, Cabrera Q, Zunic P, Gourin MP, Wierzbicka-Hainaut E, Viallard JF, Lavigne C, Hoarau C, Durieu I, Heiblig M, Dimicoli-Salazar S, Torregrosa-Diaz JM, Soria A, Arock M, Lortholary O, Bodemer C, Hermine O, Rossignol J; CEREMAST network. Polivka L, et al. Among authors: bulai livideanu c. J Allergy Clin Immunol. 2024 Jan;153(1):349-353.e4. doi: 10.1016/j.jaci.2023.08.015. Epub 2023 Aug 24. J Allergy Clin Immunol. 2024. PMID: 37633651 Free article.
Photo-induced graft-versus-host disease.
Hardy JM, Marguery MC, Huynh A, Borel C, Apoil PA, Lamant L, Tournier E, Alberto C, Pauwels C, Thomas M, Mazereeuw Hautier J, Paul C, Bulai Livideanu C. Hardy JM, et al. Among authors: bulai livideanu c. Photodermatol Photoimmunol Photomed. 2016 Sep;32(5-6):291-295. doi: 10.1111/phpp.12273. Epub 2016 Oct 19. Photodermatol Photoimmunol Photomed. 2016. PMID: 27623188
Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C-finding treated with midostaurin.
Heiblig M, Gourguechon C, Guilpain P, Bulai-Livideanu C, Barete S, Chantran Y, Agopian J, Brenet F, Dubreuil P, Lespinasse J, Lemal R, Tournilhac O, Terriou L, Launay D, Bouillet L, Chatain C, Damaj G, Ballul T, Greco C, Polivka L, Frenzel L, Meni C, Bouktit H, Benabou D, Gaudy-Marqueste C, Gousseff M, Le Mouel E, Neel A, Ranta D, Jaussaud R, Molina TJ, Bruneau J, Villarese P, Lhermitte L, Maouche-Chrétien L, Temple M, Kosmider O, Javier RM, Pelletier F, Castelain F, Retornaz F, Cabrera Q, Zunic P, Gourin MP, Wierzbicka-Hainaut E, Viallard JF, Lavigne C, Hoarau C, Durieu I, Dimicoli-Salazar S, Torregrosa-Diaz JM, Wemeau M, Soria A, Arock M, Bodemer C, Lortholary O, Hermine O, Rossignol J. Heiblig M, et al. Among authors: bulai livideanu c. Am J Hematol. 2024 Nov;99(11):2127-2139. doi: 10.1002/ajh.27478. Epub 2024 Sep 17. Am J Hematol. 2024. PMID: 39287048
Histological characterization of liver involvement in systemic mastocytosis.
Rossignol J, Canioni D, Aouba A, Bulai-Livideanu C, Barete S, Lancesseur C, Polivka L, Madrange M, Ballul T, Neuraz A, Greco C, Agopian J, Brenet F, Dubreuil P, Lemal R, Tournilhac O, Terriou L, Launay D, Bouillet L, Gourguechon C, Frenzel L, Meni C, Gaudy-Marqueste C, Gousseff M, Le Mouel E, Hamidou M, Neel A, Ranta D, Jaussaud R, Guilpain P, Molina TJ, Bruneau J, Lhermitte L, Garcelon N, Javier RM, Pelletier F, Castelain F, Retornaz F, Cabrera Q, Zunic P, Gourin MP, Wierzbicka-Hainaut E, Viallard JF, Lavigne C, Hoarau C, Durieu I, Heiblig M, Dimicoli-Salazar S, Torregrosa-Diaz JM, Soria A, Arock M, Lortholary O, Bodemer C, Pol S, Mallet V, Hermine O, Damaj G; on behalf the CEREMAST Network. Rossignol J, et al. Among authors: bulai livideanu c. Liver Int. 2024 Jul;44(7):1680-1688. doi: 10.1111/liv.15913. Epub 2024 Mar 30. Liver Int. 2024. PMID: 38554045
Real-life management of psoriasis with biological agents during pregnancy.
Tran C, Mahé E, Beylot-Barry M, Jullien D, Richard MA, Fougerousse AC, Bouznad A, Bulai Livideanu C, Brun A, Amelot F, Maccari F, Aubin F, Benhadou F, Paul C. Tran C, et al. Among authors: bulai livideanu c. Ann Dermatol Venereol. 2024 Jun;151(2):103254. doi: 10.1016/j.annder.2024.103254. Epub 2024 Mar 29. Ann Dermatol Venereol. 2024. PMID: 38554588
Efficacy of ustekinumab in palmoplantar pustulosis.
Hegazy S, Konstantinou MP, Bulai Livideanu C, Tauber M, Uthurriague C, Paul C. Hegazy S, et al. Among authors: bulai livideanu c. J Eur Acad Dermatol Venereol. 2018 May;32(5):e204-e206. doi: 10.1111/jdv.14718. Epub 2018 Jan 8. J Eur Acad Dermatol Venereol. 2018. PMID: 29194805 No abstract available.
Cladribine improves cutaneous manifestations, Dermatology Life Quality Index, and Mastocytosis Quality of Life of patients with mastocytosis.
Bugaut H, Maillard H, Jacobzone C, Haddad N, Le Pelletier F, Charlotte F, Arock M, Dubreuil P, Bulai Livideanu C, Hermine O, Barete S. Bugaut H, et al. Among authors: bulai livideanu c. J Am Acad Dermatol. 2024 May;90(5):1044-1046. doi: 10.1016/j.jaad.2023.12.056. Epub 2024 Jan 12. J Am Acad Dermatol. 2024. PMID: 38219804 No abstract available.
Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients.
Lourari S, Herve C, Doffoel-Hantz V, Meyer N, Bulai-Livideanu C, Viraben R, Maza A, Adoue D, Bedane C, Paul C. Lourari S, et al. Among authors: bulai livideanu c. J Eur Acad Dermatol Venereol. 2011 Oct;25(10):1238-40. doi: 10.1111/j.1468-3083.2010.03889.x. Epub 2010 Nov 4. J Eur Acad Dermatol Venereol. 2011. PMID: 21054575 Review. No abstract available.
[Bullous secondary syphilis].
Lourari S, Bulai-Livideanu C, Giordano-Labadie F, Lamant L, Launay F, Viraben R, Paul C. Lourari S, et al. Among authors: bulai livideanu c. Presse Med. 2011 May;40(5):550-3. doi: 10.1016/j.lpm.2010.11.019. Epub 2011 Jan 19. Presse Med. 2011. PMID: 21251793 French. No abstract available.
75 results